Gwini Rudo, Beaney Thomas, Kerr Gabriele, Poulter Neil R, Mwembe Desmond, Chifamba Jephat
National University of Science and Technology (NUST) Faculty of Medicine, NUST Complex Mpilo Hospital, Vera Road, Mzilikazi, PO Box 2096, Bulawayo, Zimbabwe.
Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.
Eur Heart J Suppl. 2024 Jul 24;26(Suppl 3):iii105-iii107. doi: 10.1093/eurheartjsupp/suae068. eCollection 2024 Jun.
The May Measurement Month 2021 campaign in Zimbabwe was aimed at assessing the frequency of hypertension and improving awareness among the population of the sequelae of elevated blood pressure (BP). Participants aged 18 years and above were recruited at outdoor booths to fill out a questionnaire and provide three BP measurements with 1-min intervals. Of the 2094 participants, over one-third (37.3%) were hypertensive, half of hypertensives (49.7%) were aware they had elevated pressure, and less than half (45.0%) of the hypertensive patients were on antihypertensive medications. Increasing age was directly proportional to hypertension with a large leap from 9.5 to 27.7% between the 18-29 and 30-39 age groups. Hypertension remains a major public health challenge in Zimbabwe. Improving access to preventive health screening services as well as treatment facilities is essential to early detect and control hypertension.
2021年津巴布韦的“五月测量月”活动旨在评估高血压的发病频率，并提高民众对血压升高后遗症的认识。18岁及以上的参与者在户外摊位被招募，填写问卷并每隔1分钟进行三次血压测量。在2094名参与者中，超过三分之一（37.3%）患有高血压，一半的高血压患者（49.7%）知道自己血压升高，不到一半（45.0%）的高血压患者正在服用降压药。年龄增长与高血压成正比，在18 - 29岁和30 - 39岁年龄组之间，高血压患病率从9.5%大幅跃升至27.7%。高血压仍然是津巴布韦面临的一项重大公共卫生挑战。改善预防性健康筛查服务以及治疗设施的可及性对于早期发现和控制高血压至关重要。
